Neuroblastoma classification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (4 intermediate revisions by the same user not shown) | |||
| Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
International neuroblastoma pathology classification system is used for the classification of neuroblastic tumors. It is subdivided in 02 main categories based on the [[Morphology|morphologic features]] of neuroblastic tumors into; schwannian stroma-poor and schwannian stroma-rich/dominant. | |||
==Classification== | ==Classification== | ||
* International neuroblastoma pathology classification, a system based on the framework of Shimada classification with minor modifications is proposed for international use in classification of neuroblastic tumors. <ref name="Stanford">Neuroblastoma, Ganglioneuroblastoma and Ganglioneuroma. Stanford Medicine Surgical Pathology Criteria(2015) http://surgpathcriteria.stanford.edu/srbc/neuroblastoma-ganglioneuroblastoma-ganglioneuroma/ Accessed on October, 5 2015</ref><ref name="pmid11745303">{{cite journal| author=Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, Goto S et al.| title=International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group. | journal=Cancer | year= 2001 | volume= 92 | issue= 9 | pages= 2451-61 | pmid=11745303 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11745303 }} </ref> | * International neuroblastoma pathology classification, a system based on the framework of Shimada classification with minor modifications is proposed for international use in classification of neuroblastic tumors. <ref name="Stanford">Neuroblastoma, Ganglioneuroblastoma and Ganglioneuroma. Stanford Medicine Surgical Pathology Criteria(2015) http://surgpathcriteria.stanford.edu/srbc/neuroblastoma-ganglioneuroblastoma-ganglioneuroma/ Accessed on October, 5 2015</ref><ref name="pmid11745303">{{cite journal| author=Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, Goto S et al.| title=International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group. | journal=Cancer | year= 2001 | volume= 92 | issue= 9 | pages= 2451-61 | pmid=11745303 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11745303 }} </ref><ref name="ShimadaAmbros1999">{{cite journal|last1=Shimada|first1=Hiroyuki|last2=Ambros|first2=Inge M.|last3=Dehner|first3=Louis P.|last4=Hata|first4=Jun-ichi|last5=Joshi|first5=Vijay V.|last6=Roald|first6=Borghild|last7=Stram|first7=Daniel O.|last8=Gerbing|first8=Robert B.|last9=Lukens|first9=John N.|last10=Matthay|first10=Katherine K.|last11=Castleberry|first11=Robert P.|title=The International Neuroblastoma Pathology Classification (the Shimada system)|journal=Cancer|volume=86|issue=2|year=1999|pages=364–372|issn=0008-543X|doi=10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7}}</ref> | ||
* It is a biologically relevant and pathologically significant classification system based on the morphologic features of neuroblastic tumors,i-e,neuroblastoma, ganglioneuroblastoma and ganglioneuroma. | * It is a biologically relevant and pathologically significant classification system based on the [[Morphology|morphologic features]] of neuroblastic tumors,i-e,neuroblastoma, ganglioneuroblastoma and [[ganglioneuroma]].<ref>{{Cite journal | ||
| author = [[H. Shimada]], [[I. M. Ambros]], [[L. P. Dehner]], [[J. Hata]], [[V. V. Joshi]], [[B. Roald]], [[D. O. Stram]], [[R. B. Gerbing]], [[J. N. Lukens]], [[K. K. Matthay]] & [[R. P. Castleberry]] | |||
| title = The International Neuroblastoma Pathology Classification (the Shimada system) | |||
| journal = [[Cancer]] | |||
| volume = 86 | |||
| issue = 2 | |||
| pages = 364–372 | |||
| year = 1999 | |||
| month = July | |||
| pmid = 10421273 | |||
}}</ref><ref>{{Cite journal | |||
| author = [[H. Shimada]], [[I. M. Ambros]], [[L. P. Dehner]], [[J. Hata]], [[V. V. Joshi]] & [[B. Roald]] | |||
| title = Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee | |||
| journal = [[Cancer]] | |||
| volume = 86 | |||
| issue = 2 | |||
| pages = 349–363 | |||
| year = 1999 | |||
| month = July | |||
| pmid = 10421272 | |||
}}</ref> | |||
<br> | <br> | ||
{{Family tree/start}} | {{Family tree/start}} | ||
| Line 14: | Line 34: | ||
{{familytree | | X01 | | X02 | | | | | | |X01='''Schwannian stroma-poor group'''| X02='''Schwannian stroma-rich/dominant group'''}} | {{familytree | | X01 | | X02 | | | | | | |X01='''Schwannian stroma-poor group'''| X02='''Schwannian stroma-rich/dominant group'''}} | ||
{{familytree|boxstyle= border-top: 0px;| | A01 | | A03 | | | | | | |A01=<div style="width: 20em; padding:1em;"> | {{familytree|boxstyle= border-top: 0px;| | A01 | | A03 | | | | | | |A01=<div style="width: 20em; padding:1em;"> | ||
'''Undifferentiated neuroblastoma'''<br>'''Poorly differentiated neuroblastoma'''<br>'''Differentiating neuroblastoma'''</div | '''Undifferentiated neuroblastoma'''<br>'''Poorly differentiated neuroblastoma'''<br>'''Differentiating neuroblastoma'''</div>|A03=<div style="width: 20em; padding:1em;"> | ||
'''Nodular ganglioneuroblastoma'''<br>'''Intermixed ganglioneuroblastoma'''<br>'''Maturing ganglioneuroma'''<br>'''Mature [[ganglioneuroma]]''' </div>}} | '''Nodular ganglioneuroblastoma'''<br>'''Intermixed ganglioneuroblastoma'''<br>'''Maturing ganglioneuroma'''<br>'''Mature [[ganglioneuroma]]''' </div>}} | ||
{{Family tree/end}} | {{Family tree/end}} | ||
Latest revision as of 16:49, 1 March 2019
|
Neuroblastoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Neuroblastoma classification On the Web |
|
American Roentgen Ray Society Images of Neuroblastoma classification |
|
Risk calculators and risk factors for Neuroblastoma classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Zahir Ali Shaikh, MD[2]
Overview
International neuroblastoma pathology classification system is used for the classification of neuroblastic tumors. It is subdivided in 02 main categories based on the morphologic features of neuroblastic tumors into; schwannian stroma-poor and schwannian stroma-rich/dominant.
Classification
- International neuroblastoma pathology classification, a system based on the framework of Shimada classification with minor modifications is proposed for international use in classification of neuroblastic tumors. [1][2][3]
- It is a biologically relevant and pathologically significant classification system based on the morphologic features of neuroblastic tumors,i-e,neuroblastoma, ganglioneuroblastoma and ganglioneuroma.[4][5]
Neuroblastic tumors | |||||||||||||||||||||||||||||
| Schwannian stroma-poor group | Schwannian stroma-rich/dominant group | ||||||||||||||||||||||||||||
Undifferentiated neuroblastoma Poorly differentiated neuroblastoma Differentiating neuroblastoma |
Nodular ganglioneuroblastoma Intermixed ganglioneuroblastoma Maturing ganglioneuroma Mature ganglioneuroma | ||||||||||||||||||||||||||||
References
- ↑ Neuroblastoma, Ganglioneuroblastoma and Ganglioneuroma. Stanford Medicine Surgical Pathology Criteria(2015) http://surgpathcriteria.stanford.edu/srbc/neuroblastoma-ganglioneuroblastoma-ganglioneuroma/ Accessed on October, 5 2015
- ↑ Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, Goto S; et al. (2001). "International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group". Cancer. 92 (9): 2451–61. PMID 11745303.
- ↑ Shimada, Hiroyuki; Ambros, Inge M.; Dehner, Louis P.; Hata, Jun-ichi; Joshi, Vijay V.; Roald, Borghild; Stram, Daniel O.; Gerbing, Robert B.; Lukens, John N.; Matthay, Katherine K.; Castleberry, Robert P. (1999). "The International Neuroblastoma Pathology Classification (the Shimada system)". Cancer. 86 (2): 364–372. doi:10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7. ISSN 0008-543X.
- ↑ H. Shimada, I. M. Ambros, L. P. Dehner, J. Hata, V. V. Joshi, B. Roald, D. O. Stram, R. B. Gerbing, J. N. Lukens, K. K. Matthay & R. P. Castleberry (1999). "The International Neuroblastoma Pathology Classification (the Shimada system)". Cancer. 86 (2): 364–372. PMID 10421273. Unknown parameter
|month=ignored (help) - ↑ H. Shimada, I. M. Ambros, L. P. Dehner, J. Hata, V. V. Joshi & B. Roald (1999). "Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee". Cancer. 86 (2): 349–363. PMID 10421272. Unknown parameter
|month=ignored (help)